GLUE Competitors & Alternatives
Compare Monte Rosa Therapeutics Inc with similar stocks in the same industry
Biotechnology
GLUE
Main Stock$16.52
Tradestie Score
60
Market Cap
$463.20M
Revenue Growth
-1.0%
Analyst Upside
+110.9%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$14.86
|
$2.02B | 44.5 | 49 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$10.68
|
$2.01B | - | 50 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$38.93
|
$1.97B | - | 57 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$8.17
|
$1.92B | - | 58 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$86.38
|
$1.92B | - | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$84.11
|
$1.90B | 510.6 | 56 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$32.10
|
$1.84B | - | 47 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$33.81
|
$1.81B | - | 51 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.71
|
$1.78B | - | 55 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$25.18
|
$1.78B | - | 55 | Compare |
More GLUE Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry